- US12605450utility2026C3-carbon Linked Glutarimide Degronimers for Target Protein Degradation0 cites
- US12570626utility2026Degraders and Degrons for Targeted Protein Degradation0 cites
- US12559492utility2026BRAF Degraders0 cites
- US12528797utility2026Heterocyclic Compounds for Medical Treatment0 cites
- US12486253utility2025Therapeutics for the Degradation of Mutant BRAF0 cites
- US12486290utility2025Isoindolinone and Indazole Compounds for the Degradation of EGFR0 cites
- US12454521utility2025Targeted Protein Degradation0 cites
- US12441740utility2025N/o-linked Degrons and Degronimers for Protein Degradation0 cites
- US12421220utility2025Bicyclic-substituted Glutarimide Cereblon Binders0 cites
- US12371442utility2025Isoindolinone and Indazole Compounds for the Degradation of EGFR0 cites
- US12365681utility2025Dihydrobenzimidazolones for Medical Treatment0 cites
- US12180225utility2024N/o-linked Degrons and Degronimers for Protein Degradation0 cites
- US12157735utility2024Compounds for Targeted Degradation of BRD90 cites
- US12091397utility2024Dihydroquinolinones for Medical Treatment0 cites
- US12076405utility2024Heterocyclic Degronimers for Target Protein Degradation0 cites
- US12048747utility2024Substituted Piperidine Degronimers for Target Protein Degradation0 cites
- US12048748utility2024Spirocyclic Degronimers for Target Protein Degradation0 cites
- US12049464utility2024Compounds for Targeted Degradation of BRD90 cites
- US11992531utility2024C 3 -carbon Linked Glutarimide Degronimers for Target Protein Degradation0 cites
- US11802131utility2023Glutarimides for Medical Treatment0 cites
Page 1 of 2Next →